Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H6N2O2 |
Molecular Weight | 138.124 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ONC(=O)C1=CC=CN=C1
InChI
InChIKey=IYCHDNQCHLMLJZ-UHFFFAOYSA-N
InChI=1S/C6H6N2O2/c9-6(8-10)5-2-1-3-7-4-5/h1-4,10H,(H,8,9)
Nicoxamat (nicotinohydroxamic acid) is a uricosuric drug that increased urinary excretion of urea and depressed urease activity in the stomach and the colon. Patients receiving nicoxamat showed significant improvement in blood ammonia levels as compared to patients receiving neomycin. In a double-blind clinical trial, 24 patients with the advanced chronic liver disease received 1.2 g of the drug daily. Nicoxamat induced some side effects, such as mild diarrhea, constipation, and anorexia.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2364683 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2932777 |
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis, characterisation and speciation studies of heterobimetallic pyridinehydroxamate-bridged Pt(II)/M(II) complexes (M = Cu, Ni, Zn). Crystal structure of a novel heterobimetallic 3-pyridinehydroxamate-bridged Pt(II)/Cu(II) wave-like coordination polymer. | 2005 Jun 7 |
|
Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis, characterisation and in vitro pharmacological evaluation. | 2008 May |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6217100
In a double-blind clinical trial 24 patients with advanced chronic liver disease
received 1.2 g of Nicoxamat (nicotinohydroxamic acid) daily. The drugs used in this study were uncoated white
tablets each of which contained 200 mg of nicotinohydroxamic acid.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C921
Created by
admin on Fri Dec 15 15:41:57 GMT 2023 , Edited by admin on Fri Dec 15 15:41:57 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4934
Created by
admin on Fri Dec 15 15:41:57 GMT 2023 , Edited by admin on Fri Dec 15 15:41:57 GMT 2023
|
PRIMARY | |||
|
CHEMBL504369
Created by
admin on Fri Dec 15 15:41:57 GMT 2023 , Edited by admin on Fri Dec 15 15:41:57 GMT 2023
|
PRIMARY | |||
|
DTXSID70205126
Created by
admin on Fri Dec 15 15:41:57 GMT 2023 , Edited by admin on Fri Dec 15 15:41:57 GMT 2023
|
PRIMARY | |||
|
Z3H2D4MF7A
Created by
admin on Fri Dec 15 15:41:57 GMT 2023 , Edited by admin on Fri Dec 15 15:41:57 GMT 2023
|
PRIMARY | |||
|
SUB09249MIG
Created by
admin on Fri Dec 15 15:41:57 GMT 2023 , Edited by admin on Fri Dec 15 15:41:57 GMT 2023
|
PRIMARY | |||
|
C020427
Created by
admin on Fri Dec 15 15:41:57 GMT 2023 , Edited by admin on Fri Dec 15 15:41:57 GMT 2023
|
PRIMARY | |||
|
C77068
Created by
admin on Fri Dec 15 15:41:57 GMT 2023 , Edited by admin on Fri Dec 15 15:41:57 GMT 2023
|
PRIMARY | |||
|
13997
Created by
admin on Fri Dec 15 15:41:57 GMT 2023 , Edited by admin on Fri Dec 15 15:41:57 GMT 2023
|
PRIMARY | |||
|
100000084419
Created by
admin on Fri Dec 15 15:41:57 GMT 2023 , Edited by admin on Fri Dec 15 15:41:57 GMT 2023
|
PRIMARY | |||
|
5657-61-4
Created by
admin on Fri Dec 15 15:41:57 GMT 2023 , Edited by admin on Fri Dec 15 15:41:57 GMT 2023
|
PRIMARY | |||
|
71211
Created by
admin on Fri Dec 15 15:41:57 GMT 2023 , Edited by admin on Fri Dec 15 15:41:57 GMT 2023
|
PRIMARY |
ACTIVE MOIETY